El interés en corto de Evaxion Biotech da a los inversores una idea del grado en que los inversores apuestan por la caída de las acciones de Evaxion Biotech. Los datos de interés en corto se actualizan cada dos semanas.

Evaxion Biotech (NASDAQ:EVAX) Bolsa, Informe de interés en corto

Evaxion Biotech

Evaxion Biotech AS is a clinical-stage biotech company that aspires to the exploration of artificial intelligence, or AI, to develop immunotherapies with improved efficacy when compared to currently marketed products for patients with unmet medical needs. Its pipeline programs are derived from its proprietary AI platforms, PIONEER, EDEN, RAVEN, and ObsERV. The company is utilizing these AI platforms to build a drug development pipeline. Its product candidates are; EVX-01 and EVX-02, for the treatment of various cancers, and the third candidate is cancer immunotherapy, EVX-03, for the treatment of various cancers including non-small-cell-lung-cancer, or NSCLC, is in pre-clinical development.

News

Pre-Market Outlook

Markets

Movers

Trading Ideas

ACON

ACTG

ALUR

BTAI

CNTA

DALN

DWTX

EVAX

FFBC

HYZN

LITM

MLYS

NVNI

PBBK

SEPN

STBX

TRUG

TWLO

Twilio sube un 18,5% tras superar expectativas de ingresos. Explora los movimientos clave del mercado previo de hoy.

Acciones de Twilio (TWLO) se disparan más de un 18%; 20 acciones que se mueven en el premercado de EE.UU.

IDAI

INTZ

LIDR

LKCO

LUXH

MGIH

MLGO

MRBK

MTRX

NEUP

ONDS

QRHC

RVSN

SLDP

VIRX

WTBA

Descubre las acciones que lideran los movimientos en la apertura del mercado, incluyendo repuntes destacados y caídas sorprendentes.

Acciones de Evaxion Biotech (EVAX) suben alrededor del 62%; 20 acciones que se mueven en el premercado

Long Ideas

AREN

CSTM

GDYN

GEAR

Aquí tienes cinco acciones estadounidenses que podrían llamar la atención de los inversores este viernes: CSTM, VIRX, EVAX, AREN y GDYN.

5 acciones en el foco este viernes: CSTM, VIRX, EVAX, AREN y GDYN

Evaxion Biotech A/S - American Depositary Share

Evaxion Biotech AS

<figure class="wp-block-image size-large"><img loading="lazy" decoding="async" width="1024" height="259" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/30132529/Edge-1024x259.png" alt="" class="wp-image-758730" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/30132529/Edge-1024x259.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/30132529/Edge-300x76.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/30132529/Edge-768x194.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/30132529/Edge-1536x389.png 1536w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/30132529/Edge.png 1600w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
With earnings in full swing, Wall Street's stock analysts are releasing upgrades left and right for stocks they think will soar. Above, you can see 10 of yesterday&#8217;s upgrades, including for META, from some of the best analysts in the business — and one you can ignore.
We know, because here at Benzinga, we not only keep track of every rating change and price target analysts set, but also of how accurate each analyst is.
That way you can decide whether these upgrades are worth your time. As you can see above, META, SEIC, and EW were just upgraded from Hold to Buy (or the equivalent) by analysts who are right 70% of the time or more.&nbsp;
That&#8217;s a powerful signal that these stocks deserve a closer look.
Meanwhile, you can also see that stocks such as PCRX, AKRO, and CVLT were handed upgrades by analysts who get it right less than half the time.
You&#8217;d be better off tossing a coin than following that advice.
The Benzinga analyst ratings tracker can show you upgrades and downgrades from many more analysts, including Tuesday&#8217;s upgrade on a little-known stock from an analyst who's right 80% of the time.
To get this information every day, see the rest of the list, and unlock all the major upgrades, downgrades, and changes made by Wall Street's most accurate analysts, <a href="https://www.benzinga.com/premium/ideas/benzinga-edge/?utm_source=WebRD-0131&amp;el=ResearchDaily&amp;he={{email}}&amp;adt_ei={{email}}">get instant access to Edge right here.</a>
Image via Shutterstock

Opinion

Meta Beats Earnings But Here's the Other Reason the Stock Rallied

WIIM

RTX shares are trading higher after B of A Securities raised its price target on the stock from $145 to $155.

<a href="https://medium.com/avride/avride-and-grubhub-bring-autonomous-delivery-robots-to-u-s-college-campuses-50494150ef16" title="https://medium.com/avride/avride-and-grubhub-bring-autonomous-delivery-robots-to-u-s-college-campuses-50494150ef16">https://medium.com/avride/avride-and-grubhub-bring-autonomous-delivery-robots-to-u-s-college-campuses-50494150ef16</a>

NBIS

'Avride and Grubhub Bring Autonomous Delivery Robots to U.S. College Campuses' -Avride Team Medium.com Post

Canadian Pacific Kansas shares are trading higher after Stephens & Co. and RBC Capital raised their respective price targets on the stock.

Howard Hughes Holdings's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HHH#NYSE">HHH</a>) short percent of float has risen 5.57% since its last report. The company recently reported that it has 1.81 million shares sold short, which is 5.88% of all regular shares that are available for trading. Based on its trading volume, it would take traders 3.94 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>Howard Hughes Holdings Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1738262723_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Howard Hughes Holdings has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing Howard Hughes Holdings's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Howard Hughes Holdings's peer group average for short interest as a percentage of float is 1.81%, which means the company has more short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Short Sellers

Short Ideas

How Is The Market Feeling About Howard Hughes Holdings?

Rivian Automotive's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RIVN#NYSE">RIVN</a>) short percent of float has fallen 4.22% since its last report. The company recently reported that it has 143.66 million shares sold short, which is 19.31% of all regular shares that are available for trading. Based on its trading volume, it would take traders 3.32 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>Rivian Automotive Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1738262718_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Rivian Automotive has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing Rivian Automotive's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Rivian Automotive's peer group average for short interest as a percentage of float is 7.00%, which means the company has more short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

RIVN

(RIVN) - Analyzing Rivian Automotive's Short Interest

MSCI's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MSCI#NYSE">MSCI</a>) short percent of float has fallen 5.74% since its last report. The company recently reported that it has 773 thousand shares sold short, which is 1.15% of all regular shares that are available for trading. Based on its trading volume, it would take traders 1.9 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>MSCI Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1738262713_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for MSCI has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing MSCI's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, MSCI's peer group average for short interest as a percentage of float is 3.26%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

MSCI

Looking Into MSCI's Recent Short Interest

A landmark study published Tuesday in JAMA Network Open found that both recent and lifetime cannabis use may impair brain function during cognitive tasks, particularly those involving working memory.
The <a href="https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2829657?utm_source=For_The_Media&amp;utm_medium=referral&amp;utm_campaign=ftm_links&amp;utm_term=012825" target="_blank" rel="noreferrer noopener">study</a>, the largest of its kind, examined 1,000 young adults aged 22 to 36 using brain imaging technology. Researchers found that 63% of heavy lifetime cannabis users showed reduced brain activity during a working memory task, while 68% of recent users exhibited a similar decline.
<h1 class="wp-block-heading">Implications For Memory And Cognitive Performance</h1>
Working memory plays a crucial role in everyday functions, allowing individuals to follow instructions, solve problems and process information efficiently. The decline in brain activity observed in cannabis users correlated with poorer performance on working memory tasks.
&#8220;As cannabis use continues to grow globally, studying its effects on human health has become increasingly important," <a href="https://news.cuanschutz.edu/news-stories/largest-study-ever-done-on-cannabis-and-brain-function-finds-impact-on-working-memory">said</a> lead author Joshua Gowin, Ph.D., an assistant professor of radiology at the University of Colorado School of Medicine. "By doing so, we can provide a well-rounded understanding of both the benefits and risks of cannabis use, empowering people to make informed decisions and fully comprehend the potential consequences.&#8221;
A Thursday <a href="https://news.cuanschutz.edu/news-stories/largest-study-ever-done-on-cannabis-and-brain-function-finds-impact-on-working-memory">report</a> by Julia Milzer for the Colorado Anschutz Medical Campus noted that the study categorized participants into three groups: heavy users who had consumed cannabis more than 1,000 times in their lifetime, moderate users who had consumed between 10 and 999 times and those who had used marijuana fewer than 10 times, essentially non-users.
<h1 class="wp-block-heading">Marijuana's Impact On The Brain</h1>
To assess brain function, researchers conducted MRI scans while participants completed seven cognitive tasks. The tests measured working memory, language skills, motor function, emotional processing, decision-making and social cognition. The latter refers to the processes that influence how people respond to social signals.
The most significant impact was observed in the working memory task, where cannabis users exhibited reduced brain activity in key regions, including the dorsolateral prefrontal cortex, dorsomedial prefrontal cortex and anterior insula. These areas are critical for memory, decision-making, attention and emotional regulation.
&#8220;We applied the highest standards to our research, setting rigorous thresholds for statistical significance across all seven cognitive function tests," Gowin said. "While some of the other tasks indicated potential cognitive impairment, only the working memory task showed a statistically significant impact."
<h1 class="wp-block-heading">Potential For Cognitive Recovery</h1>
While the study suggests that abstaining from cannabis before performing cognitive tasks may help improve function, Gowin cautioned against stopping abruptly.
&#8220;People need to be aware of their relationship with cannabis since stopping cold turkey could disrupt their cognition," he said. "For example, heavy users may need to be more cautious."
Looking ahead, researchers say even larger, long-term studies are needed to determine whether cannabis directly alters brain function, how long these effects last and how different age groups are affected.
Read Also: 
<ul>
<li><a href="https://www.benzinga.com/general/biotech/25/01/43278893/how-ozempic-and-legal-weed-are-changing-what-america-eats">How Ozempic And Legal Weed Are Changing What America Eats</a></li>
</ul>
Photo: Shutterstock

Cannabis

Education

Health Care

Cannabis Use Reduces Brain Activity In Cognitive Tasks, Largest Study To Date Finds

Wall Street is struggling to find risk-on momentum, with major indexes stuck near the flatline at midday as investors assess the latest earnings reports from mega-cap tech stocks and weaker-than-expected U.S. economic growth in the<a href="https://www.benzinga.com/economics/macro-economic-events/25/01/43336153/us-economy-grows-below-q4-estimates-as-consumer-spending-hits-7-quarter-high"> final quarter of 2024.</a>
After Tuesday's rally — which followed a selloff triggered by DeepSeek&#8217;s impact earlier in the week — caution has taken hold, signaling the wounds from the downturn are still fresh.
Microsoft Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NYSE">MSFT</a>) is among the hardest-hit stocks, plunging more than 6%, which could mark its worst daily decline<a href="https://www.benzinga.com/news/earnings/25/01/43333060/msft-stock-declines-over-4-in-premarket-after-q2-results-ceo-satya-nadella-says-deepseek-has-some-r"> since October 2022</a>.
Despite reporting overall stronger-than-expected earnings, Microsoft&#8217;s cloud segment, Azure, fell short of growth expectations, and the company slightly missed its revenue guidance for the ongoing quarter.
In contrast, Meta Platforms Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/META#NASDAQ">META</a>) climbed 1.7% post-earnings, reaching new all-time highs.
Another major laggard was United Parcel Service Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UPS#NYSE">UPS</a>), which plummeted 15%, potentially heading for its worst single-day drop <a href="https://www.benzinga.com/news/earnings/25/01/43335015/ups-q4-earnings-major-customer-volume-cut-raises-jitters-stock-tanks">since going public in 2002</a>.
UPS Chief Financial Officer Brian Dykes revealed during the earnings call the company reached an agreement in principle with Amazon.com (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>) to significantly cut the volume of packages it handles for the e-commerce giant, aiming for a 50% reduction by the second half of 2026.
The U.S. dollar and bond yields remained stable following the Federal Reserve's decision Wednesday to keep interest rates unchanged at 4.25%-4.5%.
Among commodities, precious metals stood out, with gold rising 1.4% to <a href="https://www.benzinga.com/news/econ-s/25/01/43348204/gold-hits-record-high-as-central-banks-ease-stance-5-mining-stocks-rally">new all-time highs </a>and silver climbing 2.4%.
Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) edged up 1% to around $105,000.
<h3 class="wp-block-heading">Thursday&#8217;s Performance In Major US Indices, ETFs</h3>
<figure class="wp-block-table is-style-stripes"> 
<table>
<tbody>
<tr>
<td>Major Indices</td>
<td>Price</td>
<td>1-day %chg</td>
</tr>
<tr>
<td>• Russell 2000</td>
<td>2,306.29</td>
<td>1.0%</td>
</tr>
<tr>
<td>• Dow Jones</td>
<td>44,866.30</td>
<td>0.3%</td>
</tr>
<tr>
<td>• S&amp;P 500</td>
<td>6,054.43</td>
<td>0.3%</td>
</tr>
<tr>
<td>• Nasdaq 100</td>
<td>21,420.81</td>
<td>0.0%</td>
</tr>
</tbody>
</table>
<figcaption class="wp-element-caption">Updated at 12:50 p.m. ET</figcaption></figure>
According to&nbsp;<a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent012925&amp;t=be2bearmibe3na1" target="_blank" rel="noreferrer noopener">Benzinga Pro</a>&nbsp;data:
<ul>
<li>The&nbsp;SPDR S&amp;P 500 ETF Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>)&nbsp;inched 0.2% higher to $603.10.</li>
<li>The&nbsp;SPDR Dow Jones Industrial Average&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DIA#NYSE">DIA</a>) edged up by 0.2% to $448.22.</li>
<li>The tech-heavy&nbsp;Invesco QQQ Trust Series&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>)&nbsp;edged 0.1% lower to $521.30.</li>
<li>The&nbsp;iShares Russell 2000 ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IWM#NYSE">IWM</a>) rose 1.2% to $228.50.</li>
<li>The&nbsp;Utilities Select Sector SPDR Fund (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLU#NYSE">XLU</a>) outperformed, up 1.7%; the&nbsp;Technology Select Sector SPDR Fund&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLK#NYSE">XLK</a>), lagged down 0.4%.</li>
</ul>
<h3 class="wp-block-heading">Thursday&#8217;s Stock Movers</h3>
<ul>
<li>Tesla Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) rose 4.4% in reaction to quarterly earnings results. </li>
<li>Other stocks reacting to earnings include:
<ul>
<li>ServiceNow Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NOW#NYSE">NOW</a>) down 12.6%</li>
<li>International Business Machines Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IBM#NYSE">IBM</a>) up 12.3%</li>
<li>Lam Research Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LRCX#NASDAQ">LRCX</a>) up 7.96%</li>
<li>Raymond James Financial Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RJF#NYSE">RJF</a>) down 1.15%</li>
<li>Ameriprise Financial Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AMP#NYSE">AMP</a>) down 3.08%</li>
<li>Waste Management Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WM#NYSE">WM</a>) up 4.53%</li>
<li>Las Vegas Sands Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LVS#NYSE">LVS</a>) up 10.4%</li>
<li>Lazard Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LAZ#NYSE">LAZ</a>) up 3.58%</li>
<li>Kirby Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KEX#NYSE">KEX</a>) up 7.22%</li>
<li>Flagstar Financial Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FLG#NYSE">FLG</a>) up 16.46%</li>
<li>Caterpillar Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CAT#NYSE">CAT</a>) down 4.43%</li>
<li>Northrop Grumman Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NOC#NYSE">NOC</a>) down 2.04%</li>
<li>Dow Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DOW#NYSE">DOW</a>) down 6.09%</li>
<li>Valero Energy Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VLO#NYSE">VLO</a>) down 2.5%, </li>
<li>Cigna Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CI#NYSE">CI</a>) down 8.46%,</li>
</ul>
</li>
<li>Major companies slated to report earnings after the close are Apple Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>), Visa Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/V#NYSE">V</a>), Intel Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INTC#NASDAQ">INTC</a>), KLA Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KLAC#NASDAQ">KLAC</a>), PPG Industries Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PPG#NYSE">PPG</a>), ResMed Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RMD#NYSE">RMD</a>), Baker Hughes Co. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BKR#NASDAQ">BKR</a>), Deckers Outdoor Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DECK#NYSE">DECK</a>) and LPL Financial Holdings Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LPLA#NASDAQ">LPLA</a>). </li>
</ul>
Read Next:
<ul>
<li><a href="https://www.benzinga.com/general/gaming/25/01/43342224/ryan-cohen-moves-gamestop-shares-to-personal-name-sparking-speculation-on-next-steps">Ryan Cohen Moves 36.8 Million GameStop Shares To Personal Name, Sparking Speculation On Next Steps</a></li>
</ul>
Photo via Shutterstock.

Equities

Commodities

$BTC

AAPL

AMZN

DECK

SPDR Dow Jones Industrial Average ETF Trust

INTC

KLAC

LPLA

LRCX

MSFT

TSLA

Wall Street Remains Flat, Microsoft Eyes Heaviest Drop Since Late 2022, Gold Sets Fresh Records: What's Driving Markets Thursday?

BABA

BIDU

Citigourp Global Markets 2% Protected Notes Linked To The Djia

XPEV

Shares of US-listed Chinese stocks are trading higher. Chinese stocks may be rising amid the Lunar New Year, recent AI developments out of China and government efforts to boost markets.

Deep-pocketed investors have adopted a bearish approach towards Snowflake (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SNOW#NYSE">SNOW</a>), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in SNOW usually suggests something big is about to happen.
We gleaned this information from our observations today when Benzinga's options scanner highlighted 51 extraordinary options activities for Snowflake. This level of activity is out of the ordinary.
The general mood among these heavyweight investors is divided, with 39% leaning bullish and 43% bearish. Among these notable options, 8 are puts, totaling $364,416, and 43 are calls, amounting to $2,042,612.
<h3>What's The Price Target?</h3>
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $100.0 to $250.0 for Snowflake over the last 3 months. 
<h3>Insights into Volume &amp; Open Interest</h3>
Looking at the volume and open interest is an insightful way to conduct due diligence on a stock.
This data can help you track the liquidity and interest for Snowflake's options for a given strike price.
Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Snowflake's whale activity within a strike price range from $100.0 to $250.0 in the last 30 days. 
<h3>Snowflake Option Activity Analysis: Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1738261864_0.png" alt="Options Call Chart" />
<h3>Largest Options Trades Observed:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>SNOW</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>03/07/25</td>
<td>$8.0</td>
<td>$6.5</td>
<td>$6.5</td>
<td>$200.00</td>
<td>$163.8K</td>
<td>33</td>
<td>1.0K</td>
</tr>
<tr>
<td>SNOW</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>03/20/26</td>
<td>$48.95</td>
<td>$46.6</td>
<td>$47.17</td>
<td>$160.00</td>
<td>$94.3K</td>
<td>33</td>
<td>20</td>
</tr>
<tr>
<td>SNOW</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>03/21/25</td>
<td>$9.4</td>
<td>$9.2</td>
<td>$9.3</td>
<td>$190.00</td>
<td>$93.0K</td>
<td>3.0K</td>
<td>1.2K</td>
</tr>
<tr>
<td>SNOW</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>03/07/25</td>
<td>$6.6</td>
<td>$5.15</td>
<td>$6.6</td>
<td>$200.00</td>
<td>$75.9K</td>
<td>33</td>
<td>1.2K</td>
</tr>
<tr>
<td>SNOW</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>02/21/25</td>
<td>$1.3</td>
<td>$1.28</td>
<td>$1.3</td>
<td>$200.00</td>
<td>$71.5K</td>
<td>6.3K</td>
<td>1.2K</td>
</tr>
</tbody>
</table>

<h3>About Snowflake</h3>
Founded in 2012, Snowflake is a data lake, warehousing, and sharing company that went public in 2020. To date, the company has over 3,000 customers, including nearly 30% of the Fortune 500. Snowflake's data lake stores unstructured and semistructured data that can then be used in analytics to create insights stored in its data warehouse. Snowflake's data sharing capability allows enterprises to buy and ingest data, while its data solutions can be hosted on various public clouds.
Having examined the options trading patterns of Snowflake, our attention now turns directly to the company. This shift allows us to delve into its present market position and performance
<h3>Where Is Snowflake Standing Right Now?</h3>
<ul>
<li>Currently trading with a volume of 3,627,843, the SNOW's price is down by -2.74%, now at $177.86. </li>
<li>RSI readings suggest the stock is currently may be approaching overbought.</li>
<li>Anticipated earnings release is in 27 days.</li>
</ul>
<h3>What The Experts Say On Snowflake</h3>
Over the past month, 5 industry analysts have shared their insights on this stock, proposing an average target price of $199.8.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; Reflecting concerns, an analyst from Cantor Fitzgerald lowers its rating to Overweight with a new price target of $201. 
&#x2A; An analyst from Barclays upgraded its action to Overweight with a price target of $190. 
&#x2A; An analyst from Piper Sandler has decided to maintain their Overweight rating on Snowflake, which currently sits at a price target of $208. 
&#x2A; Maintaining their stance, an analyst from Oppenheimer continues to hold a Outperform rating for Snowflake, targeting a price of $200. 
&#x2A; An analyst from Wells Fargo has elevated its stance to Overweight, setting a new price target at $200. 
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Snowflake with <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> for real-time alerts.

Options

SNOW

Behind the Scenes of Snowflake's Latest Options Trends

Financial giants have made a conspicuous bullish move on Palo Alto Networks. Our analysis of options history for Palo Alto Networks (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PANW#NASDAQ">PANW</a>) revealed 15 unusual trades.
Delving into the details, we found 53% of traders were bullish, while 40% showed bearish tendencies. Out of all the trades we spotted, 7 were puts, with a value of $421,292, and 8 were calls, valued at $317,533.
<h3>Projected Price Targets</h3>
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $150.0 to $240.0 for Palo Alto Networks over the last 3 months. 
<h3>Volume &amp; Open Interest Trends</h3>
In terms of liquidity and interest, the mean open interest for Palo Alto Networks options trades today is 852.6 with a total volume of 954.00.
In the following chart, we are able to follow the development of volume and open interest of call and put options for Palo Alto Networks's big money trades within a strike price range of $150.0 to $240.0 over the last 30 days.
<h3>Palo Alto Networks Option Activity Analysis: Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1738261859_0.png" alt="Options Call Chart" />
<h3>Significant Options Trades Detected:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th align="right">Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>PANW</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>07/18/25</td>
<td>$8.4</td>
<td>$8.0</td>
<td>$7.9</td>
<td>$165.00</td>
<td>$173.8K</td>
<td align="right">70</td>
<td align="right">220</td>
</tr>
<tr>
<td>PANW</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>06/20/25</td>
<td>$4.65</td>
<td>$4.4</td>
<td>$4.6</td>
<td>$240.00</td>
<td>$73.6K</td>
<td align="right">550</td>
<td align="right">161</td>
</tr>
<tr>
<td>PANW</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>02/21/25</td>
<td>$13.15</td>
<td>$12.85</td>
<td>$13.15</td>
<td>$195.00</td>
<td>$55.2K</td>
<td align="right">504</td>
<td align="right">204</td>
</tr>
<tr>
<td>PANW</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>02/21/25</td>
<td>$13.15</td>
<td>$12.85</td>
<td>$13.15</td>
<td>$195.00</td>
<td>$55.2K</td>
<td align="right">504</td>
<td align="right">204</td>
</tr>
<tr>
<td>PANW</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>02/21/25</td>
<td>$14.0</td>
<td>$13.5</td>
<td>$13.5</td>
<td>$195.00</td>
<td>$40.5K</td>
<td align="right">504</td>
<td align="right">31</td>
</tr>
</tbody>
</table>

<h3>About Palo Alto Networks</h3>
Palo Alto Networks is a platform-based cybersecurity vendor with product offerings covering network security, cloud security, and security operations. The California-based firm has more than 80,000 enterprise customers across the world, including more than three fourths of the Global 2000.
Having examined the options trading patterns of Palo Alto Networks, our attention now turns directly to the company. This shift allows us to delve into its present market position and performance
<h3>Where Is Palo Alto Networks Standing Right Now?</h3>
<ul>
<li>With a volume of 1,776,624, the price of PANW is up 0.49% at $186.34. </li>
<li>RSI indicators hint that the underlying stock may be approaching overbought.</li>
<li>Next earnings are expected to be released in 19 days.</li>
</ul>
<h3>What The Experts Say On Palo Alto Networks</h3>
5 market experts have recently issued ratings for this stock, with a consensus target price of $187.6.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; An analyst from Morgan Stanley has decided to maintain their Overweight rating on Palo Alto Networks, which currently sits at a price target of $230. 
&#x2A; An analyst from Guggenheim downgraded its action to Sell with a price target of $130. 
&#x2A; Consistent in their evaluation, an analyst from Loop Capital keeps a Hold rating on Palo Alto Networks with a target price of $180. 
&#x2A; An analyst from Deutsche Bank downgraded its action to Hold with a price target of $190. 
&#x2A; An analyst from JMP Securities has revised its rating downward to Market Outperform, adjusting the price target to $208. 
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Palo Alto Networks with <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> for real-time alerts.

PANW

Palo Alto Networks's Options: A Look at What the Big Money is Thinking

Deep-pocketed investors have adopted a bearish approach towards Bank of America (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BAC#NYSE">BAC</a>), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in BAC usually suggests something big is about to happen.
We gleaned this information from our observations today when Benzinga's options scanner highlighted 13 extraordinary options activities for Bank of America. This level of activity is out of the ordinary.
The general mood among these heavyweight investors is divided, with 38% leaning bullish and 53% bearish. Among these notable options, 4 are puts, totaling $982,054, and 9 are calls, amounting to $697,850.
<h3>What's The Price Target?</h3>
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $40.0 to $48.0 for Bank of America over the last 3 months. 
<h3>Volume &amp; Open Interest Development</h3>
In terms of liquidity and interest, the mean open interest for Bank of America options trades today is 11096.7 with a total volume of 17,739.00.
In the following chart, we are able to follow the development of volume and open interest of call and put options for Bank of America's big money trades within a strike price range of $40.0 to $48.0 over the last 30 days.
<h3>Bank of America Option Activity Analysis: Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1738261853_0.png" alt="Options Call Chart" />
<h3>Biggest Options Spotted:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>BAC</td>
<td>PUT</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>01/16/26</td>
<td>$2.26</td>
<td>$2.24</td>
<td>$2.25</td>
<td>$42.00</td>
<td>$783.0K</td>
<td>33.0K</td>
<td>4.2K</td>
</tr>
<tr>
<td>BAC</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>03/21/25</td>
<td>$0.98</td>
<td>$0.97</td>
<td>$0.98</td>
<td>$48.00</td>
<td>$198.7K</td>
<td>37.5K</td>
<td>2.7K</td>
</tr>
<tr>
<td>BAC</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>03/21/25</td>
<td>$1.41</td>
<td>$1.39</td>
<td>$1.4</td>
<td>$47.00</td>
<td>$115.0K</td>
<td>9.4K</td>
<td>2.2K</td>
</tr>
<tr>
<td>BAC</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/31/25</td>
<td>$4.95</td>
<td>$4.9</td>
<td>$4.9</td>
<td>$42.00</td>
<td>$98.9K</td>
<td>283</td>
<td>68</td>
</tr>
<tr>
<td>BAC</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>03/20/26</td>
<td>$9.6</td>
<td>$9.4</td>
<td>$9.65</td>
<td>$40.00</td>
<td>$96.5K</td>
<td>0</td>
<td>0</td>
</tr>
</tbody>
</table>

<h3>About Bank of America</h3>
Bank of America is one of the largest financial institutions in the United States, with more than $3.0 trillion in assets. It is organized into four major segments: consumer banking, global wealth and investment management, global banking, and global markets. Bank of America's consumer-facing lines of business include its network of branches and deposit-gathering operations, retail lending products, credit and debit cards, and small-business services. The company's Merrill Lynch operations provide brokerage and wealth-management services, as does its private bank. Wholesale lines of business include investment banking, corporate and commercial real estate lending, and capital markets operations. Bank of America has operations in several countries but is primarily US-focused.
<h3>Bank of America's Current Market Status</h3>
<ul>
<li>With a trading volume of 11,248,974, the price of BAC is up by 0.01%, reaching $46.75.</li>
<li>Current RSI values indicate that the stock is may be approaching overbought.</li>
<li>Next earnings report is scheduled for 75 days from now.</li>
</ul>
<h3>Expert Opinions on Bank of America</h3>
A total of 5 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $54.2.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; Reflecting concerns, an analyst from Truist Securities lowers its rating to Buy with a new price target of $52. 
&#x2A; An analyst from Barclays persists with their Overweight rating on Bank of America, maintaining a target price of $58. 
&#x2A; Maintaining their stance, an analyst from Oppenheimer continues to hold a Outperform rating for Bank of America, targeting a price of $55. 
&#x2A; An analyst from Truist Securities has decided to maintain their Buy rating on Bank of America, which currently sits at a price target of $53. 
&#x2A; An analyst from UBS upgraded its action to Buy with a price target of $53. 
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for Bank of America, <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> gives you real-time options trades alerts.

Looking At Bank of America's Recent Unusual Options Activity

CORT

Corcept Therapeutics shares are trading higher after Canaccord Genuity raised its price target on the stock from $78 to $130.

GOLD

SBSW

Shares of gold stocks are trading higher amid a rise in the price of gold.

Goldman Sachs analyst Brooke Roach reiterated a<a href="https://www.benzinga.com/quote/VFC/analyst-ratings"> Neutral rating</a> on the shares of VF Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VFC#NYSE">VFC</a>) and raised the price target from $22 to $25.
VFC delivered a broad-based <a href="https://www.benzinga.com/news/earnings/25/01/43302258/apparel-company-vf-corp-beats-q3-expectations-north-face-climbs-vans-slips">third-quarter beat</a>, and raised its full-year 2025 free cash flow guidance, said the analyst.
However, the company provided a fourth-quarter revenue forecast below consensus, primarily due to wholesale timing shifts and foreign exchange impacts. 
Overall, the analyst remains positive about the company&#8217;s progress with its Reinvent strategy, noting continued improvements in execution during the quarter.
According to the analyst, key highlights from the quarter include, year-over-year revenue growth for the first time in nine quarters, driven by growth across all regions, strong performances from TNF and Timberland, and sequential improvement at Vans with favorable comparisons.
The analyst also highlighted positive year-over-year sell-through for Vans in the U.S. non-value channel during the holiday season, solid gross margin expansion, benefiting from easier comparisons to last year&#8217;s inventory reset, product cost tailwinds, and lower promotional activity.
Greater-than-expected savings in SG&amp;A costs, with management on track to achieve approximately $300 million in SG&amp;A run-rate savings by the end of FY25; and ongoing debt reduction, with the company remaining on track to meet its medium-term leverage target of 2.5x or lower by FY28. 
The analyst views this quarter as a significant indication of early progress with VFC's Reinvent plan, and is optimistic about the business&#8217;s margin trajectory, especially in terms of SG&amp;A.
The analyst is eager to receive a more detailed update on the recent performance and future strategy of each brand during the second segment of the <a href="https://www.benzinga.com/calendars/guidance">company's Investor Day, scheduled for March 6.</a>
Price Action: VFC shares are trading higher by 4.65% at $26.75 at the last check Thursday.
Photo via Shutterstock.

Analyst Color

Price Target

Reiteration

Analyst Ratings

General

North Face Parent VF Corp's Q3 Marks First Revenue Growth In Nine Quarters, But Goldman Sachs Stays Neutral

HWKN

Hawkins shares are trading lower following a Q3 earnings miss.

Dolby Laboratories shares are trading higher after the company reported better-than-expected Q1 financial results.

RBC Capital Markets analyst Ken Herbert cut the price forecast for General Dynamics Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GD#NYSE">GD</a>) to $280 from $290, while <a href="https://www.benzinga.com/quote/GD/analyst-ratings">reiterating an Sector Perform rating</a>.
On Wednesday, the company reported revenue growth of 14.3% year over year to $13.338 billion, beating the consensus of $12.77 billion and EPS of $4.15 (up 14% <a href="https://www.benzinga.com/25/01/43305515/general-dynamics-beats-q4-expectations-with-144-billion-contract-backlog">Y/Y), above the consensus of $4.10</a>.
In its conference call, the company said it expects a 2025 effective tax rate of 17.5%. The CEO said Gulfstream deliveries will be around 150 aircraft in 2025.
Also, the company expects 2025 total revenue of $50.3 billion and company-wide&nbsp;<a href="https://www.benzinga.com/calendars/guidance" target="_blank" rel="noreferrer noopener">EPS to be around $14.80.</a>
The analyst writes that he remains optimistic about the 2025 Gulfstream outlook, however, muted free cash flow and limited margin expansion in defense, coupled with heightened uncertainty in the sector, remains a matter of concern.
In particular, Herbert recognized the execution challenges at Gulfstream but acknowledge the strong business jet demand, reflected in a 1x book-to-bill ratio for fourth-quarter 2024.
Following the company's revised 2025 guidance, the analyst now projects 150 deliveries in 2025 and 160 in 2026.
Additionally, aircraft services could offer upside potential with low double-digit growth, adds the analyst.
Apart from this, the analyst says that the submarine supply chain continues to face significant constraints, leading to persistent margin underperformance.
While revenue growth remains strong, Herbert remain cautious about the pace of margin improvement.
For 2026, the analyst expects overall defense portfolio margins to remain flat at approximately 9.5%, consistent with 2024 levels.
Also, the analyst believes that Trump 2.0 can pose greater risk for the GD defense portfolio outside of Marine.
Investors can gain exposure to the stock via&nbsp;Global X Funds Global X Defense Tech ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SHLD#NYSE">SHLD</a>)and&nbsp;First Trust Exchange-Traded Fund First Trust Indxx Aerospace &amp; Defense ETF&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MISL#NYSE">MISL</a>).
Price Action: GDS shares are up 1.54% at $255.31 at the last check Thursday.
Read Next:<a href="https://www.benzinga.com/25/01/43232316/deepseek-jitters-shatter-us-tech-stocks-wipe-out-12-trillion-on-wall-street-analyst-eyes-four-chinese-giants-set-to-benefit"></a>
<ul>
<li><a href="https://www.benzinga.com/25/01/43232316/deepseek-jitters-shatter-us-tech-stocks-wipe-out-12-trillion-on-wall-street-analyst-eyes-four-chinese-giants-set-to-benefit">DeepSeek Jitters Shatter US Tech Stocks, Wipe Out $1.2 Trillion On Wall Street: Analyst Eyes Four Chinese Giants Set To Benefit</a></li>
</ul>
Photo via Shutterstock.

Large Cap

MISL

SHLD

General Dynamics' Growth Vs. Uncertainty: Analyst Flags Margin Challenges And Policy Risks

Goldman Sachs analyst Jerry Revich, <a href="https://www.benzinga.com/quote/cat/analyst-ratings">maintaining a Buy rating and $442 price forecast</a>, expressed views on Caterpillar, Inc.'s (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CAT#NYSE">CAT</a>) mixed fourth quarter FY24 results reported today.
Total sales and revenue for the quarter declined 5% year-over-year to $16.215 billion, missing the consensus of $16.411 billion, while adjusted earnings of $5.14 per share came <a href="https://www.benzinga.com/25/01/43335504/caterpillar-beats-q4-eps-estimates-but-revenue-disappoints-machinery-energy-transportation-segment-faces-pressure">above the consensus of $4.99</a>.
For 2025,&nbsp;sales are expected to decline ~1%&nbsp;due to unfavorable pricing, with a slight headwind in other income from <a href="https://www.benzinga.com/calendars/guidance">lower interest income and currency effects</a>.
The analyst writes that the key discussion around the company is whether the 2025 margin outlook represents a cyclical trough following its fourth-quarter results.
The results highlighted positives such as a sharp increase in destocking ($700 million) and a book-to-bill ratio of 1.08x in orders, adds the analyst. 
However, concerns remain over 2025 margin targets, which are approximately 200 basis points below FactSet consensus, and a fourth-quarter EBIT miss—though the latter is seen as less significant given destocking progress, writes the analyst.
Revich says that while he expects to decline due to the reset in 2025 estimates, the peak of destocking headwinds, strong bookings, and effective cost management amid production cuts could support multiple expansion post-earnings.
The analyst estimates EPS of $21.68 for FY25 and $23.33 for FY26.
Price Action: CAT shares are down 4.51% at $375.51 at the last check Thursday.
Read Next:<a href="https://www.benzinga.com/25/01/43330328/us-stocks-set-for-gains-ahead-of-q1-gdp-apple-earnings"></a>
<ul>
<li><a href="https://www.benzinga.com/25/01/43330328/us-stocks-set-for-gains-ahead-of-q1-gdp-apple-earnings">US Stocks Set For Gains Ahead Of Q1 GDP, Apple Earnings: Expert Says &#8216;Higher January&#8217; Bodes Well For The Rest Of The Year</a></li>
</ul>
Photo via Shutterstock.

Caterpillar Has Potential For Multiple Expansion Post Earnings, Goldman Sachs Says

An update from Evaxion Biotech ( ($EVAX) ) is now available. On January 14, 2025, Evaxion Biotech announced the effective change in its American De...

Evaxion Biotech Announces ADS Ratio Change to Boost Liquidity

An update from Evaxion Biotech ( ($EVAX) ) is now available. On January 15, 2025, Evaxion Biotech announced the completion of dosing in a phase 2 t...

Evaxion Biotech Completes Dosing in Phase 2 Cancer Vaccine Trial

Evaxion Biotech (EVAX) has now completed the dosing of all 16 patients in its phase 2 trial with the company's lead asset EVX-01. Designed with Eva...

Evaxion Biotech completes dosing in phase 2 trial with EVX-01

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include:&nbsp...

Biotech Alert: Searches spiking for these stocks today

Evaxion Biotech (EVAX) has received notice from the Nasdaq Stock Market that it has been granted a 180-day extension to comply with Nasdaq's minimu...

Evaxion Biotech granted 180-day compliance extension by Nasdaq

Evaxion granted 180-day compliance extension by Nasdaq

An announcement from Evaxion Biotech ( ($EVAX) ) is now available. On January 28, 2025, Evaxion Biotech announced it received a 180-day extension f...

Evaxion Secures Nasdaq Compliance Extension Amid Equity Restoration

Evaxion Biotech ( ($EVAX) ) has provided an update. On January 30, 2025, Evaxion Biotech announced the pricing of a $10.8 million public offering o...

Evaxion Biotech Announces $10.8 Million Public Offering to Advance Vaccine Development

Evaxion Biotech stock slides after pricing $10.8M securities offering

ANIX

ATXI

ELAB

ERNA

GBIO

KROS

LEXX

LTRN

OSTX

RGNX

RNAZ

SNGX

TNFA

TVGN

WINT

Press Releases

Evaxion to present preclinical Proof-of-Concept for precision ERV cancer vaccine concept at ESMO Immuno-Oncology Congress

Evaxion announces 2025 milestones reflecting continued strong strategy execution

Evaxion establishes new AI-derived precision cancer vaccine concept

Evaxion pursues agreement with EIB to bolster equity through conversion of debt into equity

Evaxion announces plan to implement ADS ratio change

Evaxion announces extension to January 14, 2025, of plan to implement ADS ratio change

Evaxion announces completion of ADS ratio change

Evaxion completes dosing in phase 2 trial with personalized cancer vaccine EVX-01

Evaxion granted 180-day compliance extension by Nasdaq as it restores equity above minimum requirement

Evaxion announces pricing of $10.8 million public offering

AEON Biopharma, Inc. Class A Common Stock

AEON Biopharma

Ainos

Allarity Therapeutics, Inc. - Common stock

Allarity Therapeutics

Alzamend Neuro

Apollomics Inc. - Class A Ordinary Shares

Apollomics

Aptorum Group Limited - Class A Ordinary Shares

Aptorum Gr

Aptevo Therapeutics

BioCardia

Can-Fite Biopharma Ltd Sponsored ADR (Israel)

Can Fite Biofarma

Cellectar Biosciences, Inc. - Common Stock

Cellectar Biosciences

Cyclerion Therapeutics, Inc. - Common Stock

Cyclerion Therapeutics

Ensysce Biosciences

Galecto

Kazia Therapeutics Limited - American Depositary Shares

Kazia Therapeutics

Mustang Bio

Ocean Biomedical

Psyence Biomedical Ltd. - Ordinary Shares

Psyence Biomedical

Comments

Evaxion Biotech

Interés en corto

Evaxion Biotech (NASDAQ:EVAX) Bolsa, Informe de interés en corto

La gente también mira

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL